NOG Chromosome 17
Noggin
Upload your DNA to see your personal genotypes for variants in NOG.
What This Gene Does
The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008]
Associated Conditions (8)
NOG-related disorder
Tarsal-carpal coalition syndrome
Brachydactyly type B2
Proximal symphalangism 1A
Symphalangism-brachydactyly syndrome
Stapes ankylosis with broad thumbs and toes
Inborn genetic diseases
NOG-related-symphlangism spectrum disorder
Key Variants
RS1018505000
Conflicting classifications of pathogenicity
NOG-related disorder, NOG-related disorder
Health Risk
RS104894610
Conflicting classifications of pathogenicity
Tarsal-carpal coalition syndrome, Tarsal-carpal coalition syndrome, Brachydactyly type B2
Health Risk
RS199566527
Conflicting classifications of pathogenicity
NOG-related disorder, NOG-related disorder
Health Risk
RS104894615
Likely pathogenic
Symphalangism-brachydactyly syndrome, Inborn genetic diseases, Symphalangism-brachydactyly syndrome
Health Risk
RS1064796941
Likely pathogenic
Health Risk
RS121908949
Likely pathogenic
Brachydactyly type B2, NOG-related disorder, Brachydactyly type B2
Health Risk
RS1567745111
Likely pathogenic
Proximal symphalangism 1A, Proximal symphalangism 1A
Health Risk
RS1597920017
Likely pathogenic
Health Risk
RS2145567535
Likely pathogenic
Proximal symphalangism 1A, Proximal symphalangism 1A
Health Risk
RS2545137784
Likely pathogenic
NOG-related disorder, NOG-related disorder
Health Risk
RS2545137806
Likely pathogenic
Health Risk
RS2545137857
Likely pathogenic
Stapes ankylosis with broad thumbs and toes, Stapes ankylosis with broad thumbs and toes
Health Risk
All Variants (39)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1018505000 | Health Risk | Conflicting classifications of pathogenicity | NOG-related disorder, NOG-related disorder |
| RS104894610 | Health Risk | Conflicting classifications of pathogenicity | Tarsal-carpal coalition syndrome, Tarsal-carpal coalition syndrome, Brachydactyly type B2 |
| RS199566527 | Health Risk | Conflicting classifications of pathogenicity | NOG-related disorder, NOG-related disorder |
| RS104894615 | Health Risk | Likely pathogenic | Symphalangism-brachydactyly syndrome, Inborn genetic diseases, Symphalangism-brachydactyly syndrome |
| RS1064796941 | Health Risk | Likely pathogenic | — |
| RS121908949 | Health Risk | Likely pathogenic | Brachydactyly type B2, NOG-related disorder, Brachydactyly type B2 |
| RS1567745111 | Health Risk | Likely pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS1597920017 | Health Risk | Likely pathogenic | — |
| RS2145567535 | Health Risk | Likely pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS2545137784 | Health Risk | Likely pathogenic | NOG-related disorder, NOG-related disorder |
| RS2545137806 | Health Risk | Likely pathogenic | — |
| RS2545137857 | Health Risk | Likely pathogenic | Stapes ankylosis with broad thumbs and toes, Stapes ankylosis with broad thumbs and toes |
| RS2545137863 | Health Risk | Likely pathogenic | NOG-related disorder, NOG-related disorder |
| RS104894603 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS104894608 | Health Risk | Pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS104894609 | Health Risk | Pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS104894612 | Health Risk | Pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS104894613 | Health Risk | Pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS104894614 | Health Risk | Pathogenic | Stapes ankylosis with broad thumbs and toes, Stapes ankylosis with broad thumbs and toes |
| RS121908948 | Health Risk | Pathogenic | Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS1354515769 | Health Risk | Pathogenic | NOG-related-symphlangism spectrum disorder, NOG-related-symphlangism spectrum disorder |
| RS1567745119 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS1597919829 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS2052465606 | Health Risk | Pathogenic | Inborn genetic diseases, Inborn genetic diseases |
| RS2052469986 | Health Risk | Pathogenic | — |
| RS2052470053 | Health Risk | Pathogenic | Inborn genetic diseases, Inborn genetic diseases |
| RS2052471344 | Health Risk | Pathogenic | — |
| RS2145567008 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS2145567621 | Health Risk | Pathogenic | NOG-related disorder, NOG-related disorder |
| RS2545137908 | Health Risk | Pathogenic | — |
| RS2545137910 | Health Risk | Pathogenic | Stapes ankylosis with broad thumbs and toes, Stapes ankylosis with broad thumbs and toes |
| RS2545137924 | Health Risk | Pathogenic | — |
| RS28937580 | Health Risk | Pathogenic | Proximal symphalangism 1A, Brachydactyly type B2, Stapes ankylosis with broad thumbs and toes |
| RS387906844 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS745356934 | Health Risk | Pathogenic | Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS749247710 | Health Risk | Pathogenic | Stapes ankylosis with broad thumbs and toes, Stapes ankylosis with broad thumbs and toes |
| RS104894602 | Health Risk | Pathogenic/Likely pathogenic | Proximal symphalangism 1A, Tarsal-carpal coalition syndrome, Proximal symphalangism 1A |
| RS104894611 | Health Risk | Pathogenic/Likely pathogenic | Tarsal-carpal coalition syndrome, Proximal symphalangism 1A, Tarsal-carpal coalition syndrome |
| RS1328705140 | Health Risk | Pathogenic/Likely pathogenic | Brachydactyly type B2, Brachydactyly type B2 |